The 2024-2025 COVID-19 vaccine was associated with reduced risk for COVID-19-related major adverse cardiovascular events among older adults, especially those with comorbidities, researchers reported.Coadministration of the COVID-19 vaccine alongside the annual influenza vaccine may reduce COVID-19-related and all-cause mortality among older, higher-risk individuals, according to a study published